Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effects of once-weekly semaglutide treatment on HbA1c and body weight in people with recently diagnosed type 2 diabetes: a non-interventional, comparative effectiveness study

Authors :

Rasouli N1; Jensen AB2; Bengtsson J2; Cortes-Figueiredo F2; Deinega A2; Kushner P3

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download the poster (.pdf)
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Clinical